Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Recruiting · NCT07145229 · Registry updated 2025-12-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Nutritional and Metabolic Diseases, arthritic joint disease, arthropathy, gout, hereditary disease, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, musculoskeletal system disorder, rheumatic disorder | Recruiting | Phase 2 | 2025-12-08 | NCT07145229 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atom Therapeutics Co., Ltd | 4 |
38 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.